File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Inhalation of glutamic acid decarboxylase 65-derived peptides can protect against recurrent autoimmune but not alloimmune responses in the non-obese diabetic mouse

TitleInhalation of glutamic acid decarboxylase 65-derived peptides can protect against recurrent autoimmune but not alloimmune responses in the non-obese diabetic mouse
Authors
KeywordsBystander regulation
GAD 65
Islet transplantation
NOD mice
Peptide inhalation
Recurrent autoimmunity
Issue Date2007
Citation
Clinical and Experimental Immunology, 2007, v. 148 n. 2, p. 368-372 How to Cite?
AbstractSystemic administration of islet-derived antigens has been shown to protect against diabetes in the non-obese diabetic (NOD) mouse by the induction of antigen-specific regulatory T cells. Bystander regulation to related and unrelated islet-derived antigens (intramolecular and intermolecular recognition) in this context is recognized. We tested if intranasal administration of glutamic acid decarboxylase 65 (GAD 65)-derived peptides could protect against both autoimmune and, through bystander regulation, alloimmune responses in a NOD mouse model. Spontaneously diabetic female NOD mice underwent islet transplantation from either C57Bl/6 or NOD islet donors. Islet recipients were treated with intranasal GAD 65-derived peptides or control (ovalbumin) peptide pre- and post-transplantation. In-vitro analysis of the effect of inhalation was defined using lymph node proliferation assays and supernatant analysis for cytokines. GAD 65-derived peptide inhalation resulted in significant protection against recurrent autoimmune disease, with the generation of an interleukin (IL)-10-producing immune phenotype in a syngeneic islet transplant model. This phenotype, however, was not robust enough to protect against alloimmune responses. Inhalation of GAD-derived peptides induces an immunoregulatory response that protects against recurrent autoimmune, but not alloimmune responses in the NOD mouse. © 2007 British Society for Immunology.
Persistent Identifierhttp://hdl.handle.net/10722/195447
ISSN
2023 Impact Factor: 3.4
2023 SCImago Journal Rankings: 1.114
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorRavanan, R-
dc.contributor.authorWong, SF-
dc.contributor.authorMorgan, NG-
dc.contributor.authorMathieson, PW-
dc.contributor.authorSmith, RM-
dc.date.accessioned2014-02-28T06:12:10Z-
dc.date.available2014-02-28T06:12:10Z-
dc.date.issued2007-
dc.identifier.citationClinical and Experimental Immunology, 2007, v. 148 n. 2, p. 368-372-
dc.identifier.issn0009-9104-
dc.identifier.urihttp://hdl.handle.net/10722/195447-
dc.description.abstractSystemic administration of islet-derived antigens has been shown to protect against diabetes in the non-obese diabetic (NOD) mouse by the induction of antigen-specific regulatory T cells. Bystander regulation to related and unrelated islet-derived antigens (intramolecular and intermolecular recognition) in this context is recognized. We tested if intranasal administration of glutamic acid decarboxylase 65 (GAD 65)-derived peptides could protect against both autoimmune and, through bystander regulation, alloimmune responses in a NOD mouse model. Spontaneously diabetic female NOD mice underwent islet transplantation from either C57Bl/6 or NOD islet donors. Islet recipients were treated with intranasal GAD 65-derived peptides or control (ovalbumin) peptide pre- and post-transplantation. In-vitro analysis of the effect of inhalation was defined using lymph node proliferation assays and supernatant analysis for cytokines. GAD 65-derived peptide inhalation resulted in significant protection against recurrent autoimmune disease, with the generation of an interleukin (IL)-10-producing immune phenotype in a syngeneic islet transplant model. This phenotype, however, was not robust enough to protect against alloimmune responses. Inhalation of GAD-derived peptides induces an immunoregulatory response that protects against recurrent autoimmune, but not alloimmune responses in the NOD mouse. © 2007 British Society for Immunology.-
dc.languageeng-
dc.relation.ispartofClinical and Experimental Immunology-
dc.subjectBystander regulation-
dc.subjectGAD 65-
dc.subjectIslet transplantation-
dc.subjectNOD mice-
dc.subjectPeptide inhalation-
dc.subjectRecurrent autoimmunity-
dc.titleInhalation of glutamic acid decarboxylase 65-derived peptides can protect against recurrent autoimmune but not alloimmune responses in the non-obese diabetic mouse-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1111/j.1365-2249.2007.03358.x-
dc.identifier.pmid17437424-
dc.identifier.scopuseid_2-s2.0-34247160441-
dc.identifier.volume148-
dc.identifier.issue2-
dc.identifier.spage368-
dc.identifier.epage372-
dc.identifier.isiWOS:000245603800019-
dc.identifier.issnl0009-9104-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats